AllianceBernstein
ALBO

AllianceBernstein’s Albireo Pharma Inc ALBO Stock Holding History

AllianceBernstein’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,200
Closed -$545K – 3263
2022
Q4 		$545K Buy
25,200
+2,300
+10% +$48.6K ﹤0.01% 2584
2022
Q3 		$443K Hold
22,900
– – ﹤0.01% 2704
2022
Q2 		$455K Hold
22,900
– – ﹤0.01% 2716
2022
Q1 		$683K Buy
22,900
+100
+0.4% +$2.93K ﹤0.01% 2558
2021
Q4 		$531K Hold
22,800
– – ﹤0.01% 2716
2021
Q3 		$711K Hold
22,800
– – ﹤0.01% 2627
2021
Q2 		$802K Buy
22,800
+2,000
+10% +$65K ﹤0.01% 2625
2021
Q1 		$733K Hold
20,800
– – ﹤0.01% 2524
2020
Q4 		$780K Sell
20,800
-1,800
-8% -$65.5K ﹤0.01% 2404
2020
Q3 		$754K Buy
22,600
+7,200
+47% +$210K ﹤0.01% 2307
2020
Q2 		$408K Buy
15,400
+4,100
+36% +$96.7K ﹤0.01% 2734
2020
Q1 		$185K Buy
+11,300
New +$248K ﹤0.01% 2819
2019
Q3 		– Sell
-6,400
Closed -$206K – 3189
2019
Q2 		$206K Buy
+6,400
New +$214K ﹤0.01% 2956
2014
Q2 		– Sell
-15
Closed -$1K – 3689
2014
Q1 		$1K Hold
15
– – ﹤0.01% 3574
2013
Q4 		$1K Hold
15
– – ﹤0.01% 3379
2013
Q3 		$1K Buy
+15
New +$1.95K ﹤0.01% 3394

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AllianceBernstein's ALBO Position: Q1 2023 in Review

AllianceBernstein sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 25,200 shares — an estimated $545K sold.

AllianceBernstein first reported a position in ALBO in Q3 2013 and held it in 16 quarters. The position peaked at $802K in Q2 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • AllianceBernstein reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • AllianceBernstein sold 25,200 Albireo Pharma Inc shares in Q1 2023, an estimated $545K.
  • AllianceBernstein first reported a position in Albireo Pharma Inc in Q3 2013 and held it in 16 quarters.
  • AllianceBernstein's Albireo Pharma Inc position peaked at $802K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on AllianceBernstein's 13F filing for Q1 2023, filed 15 May 2023.